Close Menu
default event image

Infectious Diseases Spring Symposium 2022

Description

This conference will provide practitioners with the most recent advances and information to enhance knowledge, skills and performance in the treatment and diagnosis of infectious diseases. The 2022 symposium will include updates on COVID-19, PrEP and more.

Sign Up

 

Purpose

The Infectious Diseases Spring Symposium will update health professionals regarding infectious diseases so that infections can be better diagnosed, treated and prevented.

Designed For

Physicians, nurse practitioners, physician assistants, pharmacists, medical technologists, public health professionals, fellows, residents, students and other interested health care providers

Jointly Provided By

  • Creighton University School of Medicine
  • CHI Health
  • Creighton University Office of Continuing Education

Objectives

  • Describe one new culture-based method for the diagnosis of infectious diseases
  • Describe one new direct specimen method for the diagnosis of infectious diseases
  • Describe one new method for determining antimicrobial susceptibility
  • Describe current recommendations for pneumococcal vaccination in older adults
  • Describe current recommendations for pneumococcal vaccination in younger adults
  • List principal benefits and harms of COVID-19 vaccines currently used in the US
  • Define PrEP
  • List who qualifies for PrEP
  • Explain recommendations for testing and counseling prior to starting PrEP
  • Discuss the recommended PrEP regimens, dosing schedule, including dosing, safety, efficacy.
  • Describe recommended clinical and laboratory monitoring for persons receiving PrEP
  • Review gender inequities in PrEP
  • Define on demand PrEP

Schedule

9:30 a.m.
Welcome/Program Overview
Marvin J. Bittner MD, MSc, FACP, FIDSA, FSHEA

9:35 a.m.
COVID Therapeutics: What’s New?
David S. Quimby, MD
Christopher J. Destache, PharmD, FCCP

10:05 a.m.
Epidemiology and Natural History: Post Covid/Long Covid
Maureen R. Tierney, MD, MS
Nikhil Jagan, MBBS

10:45 a.m.
Modern Diagnostics in Clinical Microbiology
Stephen J. Cavalieri, PhD, D(ABMM)

11:15 a.m.
Break and Visit Virtual Exhibits

11:45 a.m.
Vaccine Update: Pneumococcal, COVID-19
Marvin J. Bittner MD, MSc, FACP, FIDSA, FSHEA

12:15 p.m.
What’s Hot About STIs
Kelsey Witherspoon, MD

12:45 p.m.
PrEPare for PrEP:  What is it all about?
Manasa Velagapudi, MBBS

1:15 p.m.
Program Concludes

Education Credits

Category 1
Creighton University Health Sciences Continuing Education designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credit(s) TM.  Physicians should claim only credit commensurate with the extent of their participation in the activity.

AAPA accepts AMA category 1 credit for the PRA from organizations accredited by ACCME.

Nurse CE
Creighton University Health Sciences Continuing Education designates this activity for 3.25 contact hours for nurses.  Nurses should claim only credit commensurate with the extent of their participation in this activity.

Pharmacy
Creighton University Health Sciences Continuing Education (HSCE) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education (CPE). The Infectious Diseases Spring Symposium 2022 is accredited for 3.25 hour(s) for completion of all CE Sessions on April 23, 2022.  The Infectious Diseases Spring Symposium 2022 is a knowledge-based activity.

Medical Assistant
The AAMA will accept a program for recertification if its subject matter is relevant to your profession. Visit the AAMA website to view more information: https://www.aama-ntl.org/continuing-education/faqs-recertification

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Creighton University Health Sciences Continuing Education and CHI Health. Creighton University Health Sciences Continuing Education (HSCE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.

Registration

Virtual Conference: $10

Refund Policy 

Continuing education and professional development courses may be cancelled by the attendee in writing up to 7 days before the course begins for a full refund. No refund will be given 7 days prior to the course. Some courses are not eligible for a refund; these exceptions are noted in specific course descriptions. If a course is cancelled by the University for non-weather related issues, the student will be notified and a full refund will be processed. In the event of a weather related closure, the course will be rescheduled.

Register for Event

Date and Time

to
Add to Calendar 20220423T093000Z 20220423T131500Z America/Chicago Infectious Diseases Spring Symposium 2022 <p>This conference will provide practitioners with the most recent advances and information to enhance knowledge, skills and performance in the treatment and diagnosis of infectious diseases. The 2022 symposium will include updates on COVID-19, PrEP and more.</p> <h1><a href="https://choose.creighton.edu/register/?id=e3a9c043-75e8-44d2-81b5-5955dbbb55c9" target="_blank">Sign Up</a></h1> <p>&nbsp;</p> <h2>Purpose</h2> <p>The Infectious Diseases Spring Symposium will update health professionals regarding infectious diseases so that infections can be better diagnosed, treated and prevented.</p> <h2>Designed For</h2> <p>Physicians, nurse practitioners, physician assistants, pharmacists, medical technologists, public health professionals, fellows, residents, students and other interested health care providers</p> <h2>Jointly Provided By</h2> <ul> <li>Creighton University School of Medicine</li> <li>CHI Health</li> <li>Creighton University Office of Continuing Education</li> </ul> <h2>Objectives</h2> <ul> <li>Describe one new culture-based method for the diagnosis of infectious diseases</li> <li>Describe one new direct specimen method for the diagnosis of infectious diseases</li> <li>Describe one new method for determining antimicrobial susceptibility</li> <li>Describe current recommendations for pneumococcal vaccination in older adults</li> <li>Describe current recommendations for pneumococcal vaccination in younger adults</li> <li>List principal benefits and harms of COVID-19 vaccines currently used in the US</li> <li>Define PrEP</li> <li>List who qualifies for PrEP</li> <li>Explain recommendations for testing and counseling prior to starting PrEP</li> <li>Discuss the recommended PrEP regimens, dosing schedule, including dosing, safety, efficacy.</li> <li>Describe recommended clinical and laboratory monitoring for persons receiving PrEP</li> <li>Review gender inequities in PrEP</li> <li>Define on demand PrEP</li> </ul> <hr /> <h2>Schedule</h2> <p><strong>9:30 a.m.<br /> Welcome/Program Overview</strong><br /> Marvin J. Bittner MD, MSc, FACP, FIDSA, FSHEA</p> <p><strong>9:35 a.m.<br /> COVID Therapeutics: What’s New?</strong><br /> David S. Quimby, MD<br /> Christopher J. Destache, PharmD, FCCP</p> <p><strong>10:05 a.m.<br /> Epidemiology and Natural History: Post Covid/Long Covid</strong><br /> Maureen R. Tierney, MD, MS<br /> Nikhil Jagan, MBBS</p> <p><strong>10:45 a.m.<br /> Modern Diagnostics in Clinical Microbiology</strong><br /> Stephen J. Cavalieri, PhD, D(ABMM)</p> <p><strong>11:15 a.m.<br /> Break and Visit Virtual Exhibits</strong></p> <p><strong>11:45 a.m.<br /> Vaccine Update: Pneumococcal, COVID-19</strong><br /> Marvin J. Bittner MD, MSc, FACP, FIDSA, FSHEA</p> <p><strong>12:15 p.m.<br /> What’s Hot About STIs</strong><br /> Kelsey Witherspoon, MD</p> <p><strong>12:45 p.m.<br /> PrEPare for PrEP:&nbsp; What is it all about?</strong><br /> Manasa Velagapudi, MBBS</p> <p><strong>1:15 p.m.<br /> Program Concludes</strong></p> <hr /> <h2>Education Credits</h2> <p><strong>Category 1</strong><br /> Creighton University Health Sciences Continuing Education designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credit(s) TM.&nbsp; Physicians should claim only credit commensurate with the extent of their participation in the activity.</p> <p>AAPA accepts AMA category 1 credit for the PRA from organizations accredited by ACCME.</p> <p><strong>Nurse CE</strong><br /> Creighton University Health Sciences Continuing Education designates this activity for 3.25 contact hours for nurses.&nbsp; Nurses should claim only credit commensurate with the extent of their participation in this activity.</p> <p><strong>Pharmacy</strong><br /> Creighton University Health Sciences Continuing Education (HSCE) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education (CPE). The Infectious Diseases Spring Symposium 2022 is accredited for 3.25 hour(s) for completion of all CE Sessions on April 23, 2022.&nbsp; The Infectious Diseases Spring Symposium 2022 is a knowledge-based activity.</p> <p><strong>Medical Assistant</strong><br /> The AAMA will accept a program for recertification if its subject matter is relevant to your profession. Visit the AAMA website to view more information: <a href="https://www.aama-ntl.org/continuing-education/faqs-recertification">https://www.aama-ntl.org/continuing-education/faqs-recertification</a></p> <p><strong>Accreditation Statement</strong></p> <p><img alt="" src="data:image/png;base64,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" style="width:100px; height:100px" /></p> <p>In support of improving patient care, this activity has been planned and implemented by Creighton University Health Sciences Continuing Education and CHI Health. Creighton University Health Sciences Continuing Education (HSCE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.</p> <h2>Registration</h2> <p>Virtual Conference: $10</p> <h2>Refund Policy&nbsp;</h2> <p>Continuing education and professional development courses may be cancelled by the attendee in writing up to 7 days before the course begins for a full refund. No refund will be given 7 days prior to the course. Some courses are not eligible for a refund; these exceptions are noted in specific course descriptions. If a course is cancelled by the University for non-weather related issues, the student will be notified and a full refund will be processed. In the event of a weather related closure, the&nbsp;course&nbsp;will&nbsp;be&nbsp;rescheduled.</p> Virtual

Location

Virtual
Tags:
Close SidebarClose Sidebar